Impact of Fc gamma receptor polymorphisms on efficacy and safety of daratumumab in relapsed/refractory multiple myeloma

Niels W.C.J. van de Donk, Tineke Casneuf, Alessandro Di Cara, Paul W. Parren, Sonja Zweegman, Berris van Kessel, Henk M. Lokhorst, Saad Z. Usmani, Sagar Lonial, Paul G. Richardson, Christopher Chiu, Tuna Mutis, Inger S. Nijhof, A. Kate Sasser

Research output: Contribution to journalLetterAcademicpeer-review

15 Citations (Scopus)
Original languageEnglish
Pages (from-to)475-479
Number of pages5
JournalBritish journal of haematology
Issue number3
Publication statusPublished - 1 Feb 2019


  • Fcγ receptors
  • daratumumab
  • immunotherapy
  • multiple myeloma
  • polymorphisms

Cite this